Literature DB >> 16247946

Zebularine: a unique molecule for an epigenetically based strategy in cancer chemotherapy. The magic of its chemistry and biology.

Victor E Marquez1, Joseph J Barchi, James A Kelley, Kambhampati V R Rao, Riad Agbaria, Tsipi Ben-Kasus, Jonathan C Cheng, Christine B Yoo, Peter A Jones.   

Abstract

1-(beta-D-ribofuranosyl)-1,2-dihydropyrimidin-2-one (zebularine) is structurally 4-deamino cytidine. The increased electrophilic character of this simple aglycon endows the molecule with unique chemical and biological properties, making zebularine a versatile starting material for the synthesis of complex nucleosides and an effective inhibitor of cytidine deaminase and DNA cytosine methyltransferase. Zebularine is a stable, antitumor agent that preferentially targets cancer cells and shows activity both in vitro and in experimental animals, even after oral administration.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16247946     DOI: 10.1081/ncn-200059765

Source DB:  PubMed          Journal:  Nucleosides Nucleotides Nucleic Acids        ISSN: 1525-7770            Impact factor:   1.381


  16 in total

1.  Exploring Synergy between Classic Mutagens and Antibiotics To Examine Mechanisms of Synergy and Antibiotic Action.

Authors:  Lisa Yun Song; Sara D'Souza; Karen Lam; Tina Manzhu Kang; Pamela Yeh; Jeffrey H Miller
Journal:  Antimicrob Agents Chemother       Date:  2015-12-28       Impact factor: 5.191

Review 2.  Chromatin, cancer and drug therapies.

Authors:  Connie C Cortez; Peter A Jones
Journal:  Mutat Res       Date:  2008-07-22       Impact factor: 2.433

3.  Novel DNA methyltransferase-1 (DNMT1) depleting anticancer nucleosides, 4'-thio-2'-deoxycytidine and 5-aza-4'-thio-2'-deoxycytidine.

Authors:  Jaideep V Thottassery; Vijaya Sambandam; Paula W Allan; Joseph A Maddry; Yulia Y Maxuitenko; Kamal Tiwari; Melinda Hollingshead; William B Parker
Journal:  Cancer Chemother Pharmacol       Date:  2014-06-08       Impact factor: 3.333

4.  HPLC method development, validation, and impurity characterization of a potent antitumor nucleoside, T-dCyd (NSC 764276).

Authors:  Mingtao Liu; Jennie Wang; Paul Liu
Journal:  J Pharm Biomed Anal       Date:  2016-09-09       Impact factor: 3.935

5.  Use of Drosophila deoxynucleoside kinase to study mechanism of toxicity and mutagenicity of deoxycytidine analogs in Escherichia coli.

Authors:  Brittany Betham; Sophia Shalhout; Victor E Marquez; Ashok S Bhagwat
Journal:  DNA Repair (Amst)       Date:  2009-12-11

6.  Demethylating drugs as novel analgesics for cancer pain.

Authors:  Chi T Viet; Dongmin Dang; Yi Ye; Kentaro Ono; Ronald R Campbell; Brian L Schmidt
Journal:  Clin Cancer Res       Date:  2014-06-24       Impact factor: 12.531

7.  Effects of a novel DNA methyltransferase inhibitor zebularine on human breast cancer cells.

Authors:  Madhavi Billam; Michele D Sobolewski; Nancy E Davidson
Journal:  Breast Cancer Res Treat       Date:  2009-05-21       Impact factor: 4.872

Review 8.  APOBEC Enzymes as Targets for Virus and Cancer Therapy.

Authors:  Margaret E Olson; Reuben S Harris; Daniel A Harki
Journal:  Cell Chem Biol       Date:  2017-11-16       Impact factor: 8.116

9.  Activation of p16 gene silenced by DNA methylation in cancer cells by phosphoramidate derivatives of 2'-deoxyzebularine.

Authors:  Christine B Yoo; Rocco Valente; Costantino Congiatu; Federica Gavazza; Annette Angel; Maqbool A Siddiqui; Peter A Jones; Christopher McGuigan; Victor E Marquez
Journal:  J Med Chem       Date:  2008-12-11       Impact factor: 7.446

10.  Effective, homogeneous and transient interference with cytosine methylation in plant genomic DNA by zebularine.

Authors:  Tuncay Baubec; Ales Pecinka; Wilfried Rozhon; Ortrun Mittelsten Scheid
Journal:  Plant J       Date:  2008-10-30       Impact factor: 6.417

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.